Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 601-650 of 6028 result(s).
CYDY CytoDyn Inc
07/08/2024 3:01:09 PM
more recent attempts to secure cash (11)
CYDY CytoDyn Inc
07/08/2024 2:45:10 PM
i think, going off Madrigal's think (15)
CYDY CytoDyn Inc
07/08/2024 2:37:46 PM
When disease is bad, Stage 4, or 5, (10)
CYDY CytoDyn Inc
07/08/2024 2:22:29 PM
The second thing is based on a comm (7)
CYDY CytoDyn Inc
07/08/2024 2:11:55 PM
What are the odds that the variants (10)
CYDY CytoDyn Inc
07/08/2024 1:59:20 PM
Perhaps the body needs some of the (15)
CYDY CytoDyn Inc
07/08/2024 1:29:33 PM
Inflammatory breast cancer is metas (7)
CYDY CytoDyn Inc
07/08/2024 1:10:19 PM
Ohm, your regulator list shows that (5)
CYDY CytoDyn Inc
07/03/2024 7:04:58 PM
Here is an abstract explaining how (16)
CYDY CytoDyn Inc
07/03/2024 6:23:25 PM
Elsewhere I explained my notion of (14)
CYDY CytoDyn Inc
07/01/2024 7:39:16 PM
CCL24 binds exclusively to the CCR3 (13)
CYDY CytoDyn Inc
07/01/2024 4:58:23 PM
Of course it's Stat News. I was goi (5)
CYDY CytoDyn Inc
07/01/2024 4:53:46 PM
Previously Authorized Monoclonal An (8)
CYDY CytoDyn Inc
07/01/2024 4:40:32 PM
That was 3-4 yrs ago. 160$ is the c (6)
CYDY CytoDyn Inc
07/01/2024 3:01:04 PM
Anybody have a subscription to Feue (6)
CYDY CytoDyn Inc
07/01/2024 2:49:36 PM
I have no idea what it costs to ac (6)
CYDY CytoDyn Inc
06/30/2024 5:44:30 PM
Guess they don't like CYDY being di (14)
CYDY CytoDyn Inc
06/30/2024 5:33:49 PM
My question to you and the board: W (4)
CYDY CytoDyn Inc
06/30/2024 9:49:12 AM
How do you know that higher levels (8)
CYDY CytoDyn Inc
06/30/2024 9:39:51 AM
Resmetirom works to reduce intra-he (5)
CYDY CytoDyn Inc
06/30/2024 9:33:29 AM
Being chronically hyperthyroid has (6)
CYDY CytoDyn Inc
06/30/2024 9:22:21 AM
I'm thinking leronlimab, by somehow (7)
CYDY CytoDyn Inc
06/30/2024 3:52:00 AM
Wonder if took resmetirom's best 22 (4)
CYDY CytoDyn Inc
06/30/2024 3:42:53 AM
Could the increases in T3 and T4 ha (11)
CYDY CytoDyn Inc
06/29/2024 10:11:37 PM
Their old CEO who has been indicted (30)
CYDY CytoDyn Inc
06/28/2024 2:34:40 PM
Maybe Ohm or someone else can speak (9)
CYDY CytoDyn Inc
06/28/2024 2:22:42 PM
Any animal studies done wouldn't ne (9)
CYDY CytoDyn Inc
06/25/2024 6:52:37 AM
Manufacturing Technology Transfer f (4)
CYDY CytoDyn Inc
06/25/2024 1:47:00 AM
Someone very nicely PMed me a link (13)
CYDY CytoDyn Inc
06/25/2024 12:54:33 AM
there was no mention of cooking fis (1)
CYDY CytoDyn Inc
06/25/2024 12:51:06 AM
So might bizaxofusp's unintended ki (10)
CYDY CytoDyn Inc
06/24/2024 9:48:59 PM
Ho Grogan hasn't had a microwave in (7)
CYDY CytoDyn Inc
06/24/2024 9:39:07 PM
Did Respert write this? (1)
CYDY CytoDyn Inc
06/24/2024 4:36:04 PM
Medicenna is seeking BTD for bizaxo (8)
CYDY CytoDyn Inc
06/24/2024 2:45:44 PM
“Some researchers think Ozempic a (28)
CYDY CytoDyn Inc
06/24/2024 1:54:38 PM
Ohm, you're certainly more knowledg (11)
CYDY CytoDyn Inc
06/24/2024 1:50:29 PM
With regards to the Alzheimer’s 2 (4)
CYDY CytoDyn Inc
06/24/2024 2:20:51 AM
Could the FDA do a EUA for Longhaul (3)
CYDY CytoDyn Inc
06/23/2024 2:13:44 PM
What does this selectivity for the (6)
CYDY CytoDyn Inc
06/23/2024 1:44:38 AM
yeah, with yellowing of skin....the (9)
CYDY CytoDyn Inc
06/23/2024 1:42:06 AM
in addition to that, the safety pro (12)
CYDY CytoDyn Inc
06/23/2024 1:36:54 AM
is the SP stuck at .14-.13, or will (12)
CYDY CytoDyn Inc
06/23/2024 1:26:06 AM
Well one thing I see right off is a (6)
CYDY CytoDyn Inc
06/23/2024 1:22:23 AM
To me, this amended warrant offer f (5)
CYDY CytoDyn Inc
06/23/2024 1:20:26 AM
I’d like to hear Ohm’s take on (15)
CYDY CytoDyn Inc
06/21/2024 12:13:34 AM
Sure feels like a hail mary to me. (17)
CYDY CytoDyn Inc
06/21/2024 12:02:14 AM
Have I correctly interpreted today' (8)
CYDY CytoDyn Inc
06/19/2024 10:01:49 PM
It could be the data is rock solid. (6)
CYDY CytoDyn Inc
06/19/2024 9:41:40 PM
"A possible prophylactic focus for (6)
CYDY CytoDyn Inc
06/19/2024 4:28:55 AM
It’s not a bad thing to increase (14)
Go to page:
  • << First
  • < Previous
  • 12
  • 13
  • Next >

Recent Articles

  • Opportunities for Hims & Hers Health Inc. Investors Amid Legal Battles
  • Consumer Tech Update: Market Adjustments and Earnings Highlights
  • Recent Developments in Tech: Intel and Nvidia Opportunities
  • GayVeteransUS-Inc Launches Support for Tennessee LGBTQ Veterans
  • Mark Cuban Contemplates Run as Trump Eyeing Third Term
  • Walmart Set for Success While Target Faces Challenges Ahead
  • Urgent Legal Steps for Hims & Hers Health Investors Ahead
  • GenScript Biotech's Impressive Growth and Sustainable Innovations
  • Bitcoin Soars Amid Federal Reserve's Optimism, Gaetz's Token Spotlights
  • Sable Offshore Corp Investors: Important Class Action Insights
  • GenScript Biotech's Exceptional Growth and Future Prospects
  • Acquire.Fi Aids Omni in Strategic Acquisition of Web3 Wallet
  • Pending Class Action for RxSight, Inc. Investors Highlights Risks
  • Understanding the Recent Simulations Plus Securities Investigation
  • Legal Action Update for Sarepta Therapeutics Investors
  • Investigation into J.M. Smucker Co. Raises Concerns for Investors
  • Innovative Moves by Tesla, Ford, and BYD in the EV Space
  • High-Stakes Investor Moves in Healthcare and Tech Sector
  • Air Canada Resumes Flights After Government Arbitration Ruling
  • Cory Thompson Announces Scholarship for Aspiring Leaders
  • Vittori's Exciting Collaboration for Advanced 3D Titanium Parts
  • Exciting Travel Offers from Travelzoo for Adventurous Travelers
  • Lianyungang's Transformation: A Gateway for Global Trade
  • Challenges of Manufacturing Smartphones in America Explored
  • Air Canada Faces Flight Operations Suspension Amid Negotiation
  • Centene Corporation Class Action Lawsuit: What Investors Need to Know
  • Investors Investigate LifeMD, Inc. After Recent Earnings Drop
  • Exciting Travel Deals Now Available in Germany for Adventurers
  • Lockheed Martin Shareholders Should Act Now Amid Lawsuit Risk
  • Sarepta Therapeutics: Join the Class Action for Compensation
  • Petco Health and Wellness Faces Class Action Deadline Soon
  • Dogecoin Investors Showcase Rugged Optimism Amid Market Decline
  • Tim Cook's Gift to Trump Reflects Apple's $100 Billion Pledge
  • AT&T Inc. Reveals $177 Million Settlement for Data Breaches
  • Overcoming the Challenges of Connected TV Advertising Today
  • The Impact of AI on Financial Markets: A Cautionary Tale
  • Kevin O'Leary's Innovative Executive Hiring Model Explained
  • New Talks Aim for Lasting Peace as Tensions Escalate
  • Innovative AI Platform from GridStrat Enhances Market Strategies
  • New Chip Export Dynamics Shaping Global Semiconductor Market
  • Investors Urged to Act as Hims & Hers Health Faces Legal Scrutiny
  • Petco Investors Examined for Claims Amid Stock Decline
  • Transforming Work: AI Replaces Soul-Crushing Jobs Amid Growth
  • Investigation Launched on Investor Claims against Centene Corp
  • John Paulson Expands Portfolio with Alphabet and Gold Miner
  • ExpandCommunication Revolutionizes Public Relations with AI
  • Important Investor Update on Sarepta Therapeutics' Safety Claims
  • Rillet Secures $70M Investment to Innovate AI in Accounting
  • Coatue Management's Strategic Bet on AI and Cloud Growth
  • Celebrate Nature With the New Luna Moth Stamp Release
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site